This material is only slightly soluble in water at a reported rate of 11.7 mg/L. The solubility of this product is tested in DMSO at a minimum rate of 20 mg/mL, with most lots soluble at 40 mg/mL. Other reported solvents include chloroform, ethanol, methanol and n-propanol. Following solubilization in any of the solvents listed above, stock solutions may typically be diluted with aqueous solvents or buffers.
F1293
Finasterid
≥98% (HPLC), Selective 5α-reductase inhibitor, powder
Synonym(e):
N-(2-methyl-2-propyl)-3-oxo-4-aza-5α-androst-1-en-17β-carboxamid, N-tert.-Butyl-3-oxo-4-aza-5α-androst-1-en-17β-carboxamid, MK-906
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Über diesen Artikel
Empirische Formel (Hill-System):
C23H36N2O2
CAS-Nummer:
Molekulargewicht:
372.54
UNSPSC Code:
41116107
PubChem Substance ID:
NACRES:
NA.77
MDL number:
Fortfahren mit
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhaltenProduktname
Finasterid, ≥98% (HPLC), powder
SMILES string
[H][C@@]12CC[C@@]3([H])[C@]4([H])CC[C@H](C(=O)NC(C)(C)C)[C@@]4(C)CC[C@]3([H])[C@@]1(C)C=CC(=O)N2
InChI key
DBEPLOCGEIEOCV-WSBQPABSSA-N
InChI
1S/C23H36N2O2/c1-21(2,3)25-20(27)17-8-7-15-14-6-9-18-23(5,13-11-19(26)24-18)16(14)10-12-22(15,17)4/h11,13-18H,6-10,12H2,1-5H3,(H,24,26)(H,25,27)/t14-,15-,16-,17+,18+,22-,23+/m0/s1
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: soluble >20 mg/mL
storage temp.
room temp
Quality Level
Gene Information
human ... HSD3B1(3283), SRD5A1(6715), SRD5A2(6716)
rat ... Hsd3b1(360348), Srd5a1(24950), Srd5a2(64677)
Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich
Verwandte Kategorien
1 of 4
Dieser Artikel | |||
|---|---|---|---|
| form powder | form powder | form powder | form - |
| assay ≥98% (HPLC) | assay ≥98% (HPLC) | assay ≥98% (HPLC) | assay - |
| Quality Level 100 | Quality Level 100 | Quality Level 100 | Quality Level - |
| storage temp. room temp | storage temp. −20°C | storage temp. 2-8°C | storage temp. 2-8°C |
| solubility DMSO: soluble >20 mg/mL | solubility DMSO: 2 mg/mL, clear | solubility DMSO: ≥15 | solubility - |
| color white to beige | color white to beige | color white to tan | color - |
Application
Finasteride has been used:
- as a component of L-15 media to investigate the effects of finasteride exposure on brain, liver and testis tissues[1]
- in culture medium to treat tumor cells in vitro[2]
- as a positive control to treat benign prostatic hyperplasia (BPH)
- to examine its effect on structural and molecular biology on the ventral prostate of senile mice[3]
Biochem/physiol Actions
Finasteride can reduce serum and scalp dihydrotestosterone (DHT) by preventing the transformation of testosterone to DHT. It is usually used to manage benign prostate hyperplasia and pattern hair loss in male. Finasteride possesses androgen-distracting properties.[1]
Selektiver 5a-Reduktasehemmer; antiandrogen.
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Repr. 1B
Lagerklasse
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
ppe
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Finasteride adverse effects: An update
Carreno-Orellana N, et al.
Revista Brasileira de Farmacognosia, 144(12), 1584-1590 (2016)
Vincent Joseph et al.
Experimental physiology, 103(2), 276-290 (2017-11-24)
What is the central question of this study? What are the contributions of allopregnanolone, the neuroactive metabolite of progesterone, and nuclear (nPR) and membrane (mPR) progesterone receptors to the respiratory effect of progesterone in newborn rats? What is the main
Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats
Jeon W Y, et al.
BMC Complementary and Alternative Medicine, 17(1), 384-384 (2017)
Finasteride in the treatment of men with androgenetic alopecia
Kaufman K D, et al.
Journal of the American Academy of Dermatology, 39(4), 578-589 (1998)
Mary K Samplaski et al.
Fertility and sterility, 100(6), 1542-1546 (2013-09-10)
To determine the degree of improvement in semen parameters after finasteride discontinuation. A prospective database of men presenting for a fertility evaluation was analyzed for semen and hormone parameters before and after discontinuation of finasteride. A male infertility specialty clinic.
-
Is this product soluble in distilled water? I need this information because I am planning a scientific experiment.
1 answer-
Helpful?
-
Active Filters
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
Setzen Sie sich mit dem technischen Dienst in Verbindung